Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-launches-non-invasive-prenatal-test-for-down-syndrome-15-years-of-research-comes-to-fruition
https://www.med.cuhk.edu.hk/press-releases/cuhk-launches-non-invasive-prenatal-test-for-down-syndrome-15-years-of-research-comes-to-fruition

CUHK Launches Non-invasive Prenatal Test for Down Syndrome 15 Years of Research Comes to Fruition

The Department of Chemical Pathology at The Chinese University of Hong Kong (CUHK) has recently launched the 'safeT21' (sensitive analysis of fetal DNA for T21 screening) test as a clinical service for the non-invasive prenatal diagnosis of Down syndrome. The test uses state-of-the-art DNA sequencing technologies to detect Down syndrome in fetuses by directly analysing a blood sample from the mother. The test is based on a discovery Professor Dennis Lo Yuk-ming, Li Ka Shing Professor of Medicine and Chairman of the Department, made in 1997 when he found that during pregnancy, the baby would release its DNA into the mother's blood plasma. This discovery has opened up new possibilities for non-invasive prenatal diagnosis.

 

(From left) Dr. Fung Tak-yuen, Chief of Service, Obstetrics and Gynaecology, Hong Kong Baptist Hospital; Dr. Yu Kai-man, Head of Obstetrics and Gynaecology Department, Union Hospital; Prof. Lo Yuk-ming Dennis, Li Ka Shing Professor of Medicine and Chairman of Department of Chemical Pathology, CUHK; Prof. Chiu Wai-kwan Rossa, Professor, Department of Chemical Pathology, CUHK; Prof. Leung Tak-yeung, Professor, Department of Obstetrics and Gynaecology, CUHK and Dr. Leung Tse-ngong Danny, Director, Maternal and Fetal Medicine, Hong Kong Sanatorium and Hospital

(From left) Dr. Fung Tak-yuen, Chief of Service, Obstetrics and Gynaecology, Hong Kong Baptist Hospital; Dr. Yu Kai-man, Head of Obstetrics and Gynaecology Department, Union Hospital; Prof. Lo Yuk-ming Dennis, Li Ka Shing Professor of Medicine and Chairman of Department of Chemical Pathology, CUHK; Prof. Chiu Wai-kwan Rossa, Professor, Department of Chemical Pathology, CUHK; Prof. Leung Tak-yeung, Professor, Department of Obstetrics and Gynaecology, CUHK and Dr. Leung Tse-ngong Danny, Director, Maternal and Fetal Medicine, Hong Kong Sanatorium and Hospital.

Down syndrome, affecting about 1 in 800 pregnancies, is caused by the presence of an additional copy of chromosome 21 in the genome of affected individuals. Down syndrome is conventionally diagnosed by analysing genetic material obtained directly from the fetus through invasive procedures such as amniocentesis and chorionic villus sampling. There is, however, about a 0.5% to 1% chance of pregnancy miscarriage associated with those invasive procedures. Hence, a non-invasive test that is based on analysing the baby's DNA in its mother's blood would remove the invasive procedure-related risk.

CUHK's team has developed a test that uses high throughput DNA sequencing technology to analyse millions of DNA fragments from a mother's blood plasma to determine if there is an elevation in the amount of chromosome 21 DNA molecules which suggests the presence of a Down syndrome fetus. The development of the test has been supported by the University Grants Committee Areas of Excellence Scheme and the Innovation and Technology Fund. The team has successfully validated this test on a large cohort of samples.

 

Prof. Lo Yuk-ming Dennis, Li Ka Shing Professor of Medicine and Chairman of Department of Chemical Pathology, CUHK introduces 'safeT21' (sensitive analysis of fetal DNA for T21 screening) test as a clinical service for the non-invasive prenatal diagnosis of Down syndrome by using the state-of-the-art DNA sequencing technologies to analyse millions of DNA fragments from a mother's blood plasma to determine if there is an elevation in the amount of chromosome 21 DNA molecules which suggests the presence of a Down syndrome fetus.

Prof. Lo Yuk-ming Dennis, Li Ka Shing Professor of Medicine and Chairman of Department of Chemical Pathology, CUHK introduces 'safeT21' (sensitive analysis of fetal DNA for T21 screening) test as a clinical service for the non-invasive prenatal diagnosis of Down syndrome by using the state-of-the-art DNA sequencing technologies to analyse millions of DNA fragments from a mother's blood plasma to determine if there is an elevation in the amount of chromosome 21 DNA molecules which suggests the presence of a Down syndrome fetus.

The team's conclusions have been supported by a number of large-scale validation clinical studies performed by other groups around the world, confirming the highly accurate diagnostic performance of the technology. As a result of these studies, the non-invasive test for Down syndrome detection has been introduced as a clinical service in Hong Kong and the United States since the end of 2011. In Hong Kong, prenatal diagnostic units at CUHK, Hong Kong Sanatorium and Hospital, Union Hospital, Hong Kong Baptist Hospital and a number of obstetrics group practices have been using the test.

It is envisioned that this non-invasive technology would increasingly be used by centres around the world and would lead to substantial reduction in the number of invasive prenatal diagnostic procedures required. This development would make prenatal testing safer and less stressful for pregnant women and their families.

 

Hotline of Non-invasive Prenatal Test for Down Syndrome: 3505 1192 (Ms Cheng/ Ms Lai)
(Service hours: 9:00am - 3:00pm, Mondays to Fridays; Callers may leave voicemails during non-service hours)

More Press Releases

CUHK Professor Dennis LO Receives 2021 Breakthrough Prize, an Honour Renowned as the “Oscars of Science”

CUHK Professor Dennis LO Receives 2021 Breakthrough Prize, an Honour Renowned as the “Oscars of Science”

Awards and honors
Professor Dennis LO Being Named as World’s “Top Translational Researchers” for Two Consecutive Years

Professor Dennis LO Being Named as World’s “Top Translational Researchers” for Two Consecutive Years

Awards and honors
‘Science is an Integral Part of My Life’ CUHK’s Prof. Dennis Lo Reaps Inaugural Future Science Prize

‘Science is an Integral Part of My Life’ CUHK’s Prof. Dennis Lo Reaps Inaugural Future Science Prize

Awards and honors
CUHK Professor Dennis LO Becomes the First Chinese Scientist to Receive the Royal Medal  for Outstanding Achievements in Biological Sciences

CUHK Professor Dennis LO Becomes the First Chinese Scientist to Receive the Royal Medal for Outstanding Achievements in Biological Sciences

Awards and honors
Two CUHK Scholars Named World’s “Top 20 Translational Researchers” Professor Dennis Lo Receiving the Honour for the Third Consecutive Year

Two CUHK Scholars Named World’s “Top 20 Translational Researchers” Professor Dennis Lo Receiving the Honour for the Third Consecutive Year

Awards and honors
CUHK Research Pioneer in Non-invasive Prenatal Diagnosis Elected to US National Academy of Sciences

CUHK Research Pioneer in Non-invasive Prenatal Diagnosis Elected to US National Academy of Sciences

Awards and honors
CUHK Professor Rossa Chiu Awarded Chinese Young Women in Science Fellowship Latest Research Breakthrough – Blood DNA Sequencing to Scan for Cancers

CUHK Professor Rossa Chiu Awarded Chinese Young Women in Science Fellowship Latest Research Breakthrough – Blood DNA Sequencing to Scan for Cancers

Awards and honors
Young Female Scientist Excels in International Arena CUHK Professor Rossa Chiu Scoops Two Research Awards

Young Female Scientist Excels in International Arena CUHK Professor Rossa Chiu Scoops Two Research Awards

Awards and honors
CUHK Receives HK$30 million Donation from Li Ka Shing Foundation to Enhance Research Space and Facilities at CU Medicine

CUHK Receives HK$30 million Donation from Li Ka Shing Foundation to Enhance Research Space and Facilities at CU Medicine

Donation
Two CUHK Scholars Named World’s “Top 20 Translational Researchers” Professor Dennis LO Receives the Honour for the Fourth Consecutive Year

Two CUHK Scholars Named World’s “Top 20 Translational Researchers” Professor Dennis LO Receives the Honour for the Fourth Consecutive Year

Awards and honors
CUHK Research Receives Recognitions by Top Medical Journals

CUHK Research Receives Recognitions by Top Medical Journals

Awards and honors
Two CUHK Medical Professors Winning WuXi PharmaTech Life Science and Chemistry Awards

Two CUHK Medical Professors Winning WuXi PharmaTech Life Science and Chemistry Awards

Awards and honors
CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

Research
CUHK Professor Dennis Lo Named ‘Thomson Reuters Citation Laureate’, an Honour Considered as an Index to Predict Nobel Prize Winners

CUHK Professor Dennis Lo Named ‘Thomson Reuters Citation Laureate’, an Honour Considered as an Index to Predict Nobel Prize Winners

Awards and honors
CUHK Professor Dennis Lo Receives Future Science Prize – Life Science Prize, the China's Nobel Prize

CUHK Professor Dennis Lo Receives Future Science Prize – Life Science Prize, the China's Nobel Prize

Awards and honors
CUHK Professor Dennis Lo as the First Chinese Honoured with AACC Wallace H. Coulter Lectureship Award

CUHK Professor Dennis Lo as the First Chinese Honoured with AACC Wallace H. Coulter Lectureship Award

Awards and honors
CUHK Professor Dennis Lo Received International Honour for Pioneering Research in Personalized Medicine

CUHK Professor Dennis Lo Received International Honour for Pioneering Research in Personalized Medicine

Awards and honors
CUHK Reveals Vasopressin Injection Can Reduce Risks of Hysteroscopic Myomectomy

CUHK Reveals Vasopressin Injection Can Reduce Risks of Hysteroscopic Myomectomy

Research
Factsheet on Personalised Medicine (Only available in Chinese Version)

Factsheet on Personalised Medicine (Only available in Chinese Version)

Research
CUHK Professor Dennis Lo Awarded King Faisal International Prize for Medicine

CUHK Professor Dennis Lo Awarded King Faisal International Prize for Medicine

Awards and honors
CUHK Launches Territory-wide Screening Study for Early Detection of Nasopharynx Cancer Now Recruiting 20,000 Citizens to Join

CUHK Launches Territory-wide Screening Study for Early Detection of Nasopharynx Cancer Now Recruiting 20,000 Citizens to Join

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.